Company intelligence / Profile preview

Ultra Pain Products

USA

Ownership: Private
Development stage: Other

Overview

Ultra Pain Products markets and distributes a portfolio of FDA-registered non-invasive medical devices for home-based pain management, including ultrasound and light therapy devices to reduce opioid reliance and promote tissue healing. Clinical usage is supported by physician adoption and home-based recovery programs, but large-scale controlled clinical results are not detailed on public records.

Therapeutic areas: CardiovascularImmunologyRheumatologyNeurologyOtherDermatology
Modalities: DeviceUltrasound therapy deviceLED light therapy deviceCompression deviceCryotherapy deviceOrthosis
Industry: Therapeutic Medical Devices

Partnerships

NanoVibronix (exclusive distributor for PainShield and PainShield Plus)

Beyond the preview

Go deeper on Ultra Pain Products.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ultra Pain Products.

Explore the full profile